Related Experiment Video
Updated: Feb 9, 2026

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans
Published on: February 27, 2018
Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts
Cristina de Castro Spadari1, Taissa Vila2, Sonia Rozental3
1Laboratório de Quimioterapia Antifúngica, Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brazil.
Abstract:
Cryptococcus spp. are common opportunistic fungal pathogens, particularly in HIV patients. The approved drug miltefosine (MFS) has potential as an alternative antifungal against cryptococcosis; however, the mechanism of action of MFS in Cryptococcus is poorly understood. Here, we examined the effects of MFS on C. neoformans and C. gattii yeasts (planktonic and biofilm lifestyles) to clarify its mechanism of action. MFS presented inhibitory and fungicidal effects against planktonic Cryptococcus cells, with similar activities against dispersion biofilm cells, while sessile biofilm cells were less sensitive to MFS. Interestingly, MFS had postantifungal effect on Cryptococcus, with a proliferation delay of up to 8.15 h after a short exposure to fungicidal doses. MFS at fungicidal concentrations increased the plasma membrane permeability, likely due to a direct interaction with ergosterol, as suggested by competition assays with exogenous ergosterol. Moreover, MFS reduced the mitochondrial membrane potential, increased reactive oxygen species (ROS) production, and induced DNA fragmentation and condensation, all of which are hallmarks of apoptosis. Transmission electron microscopy analysis showed that MFS-treated yeasts had a reduced mucopolysaccharide capsule (confirmed by morphometry with light microscopy), plasma membrane irregularities, mitochondrial swelling, and a less conspicuous cell wall. Our results suggest that MFS increases the plasma membrane permeability in Cryptococcus via an interaction with ergosterol and also affects the mitochondrial membrane, eventually leading to apoptosis, in line with its fungicidal activity. These findings confirm the potential of MFS as an antifungal against C. neoformans and C. gattii and warrant further studies to establish clinical protocols for MFS use against cryptococcosis.
Insights
Miltefosine (MFS) shows antifungal activity against Cryptococcus by disrupting cell membranes and inducing apoptosis. This drug has potential for treating cryptococcosis, especially in HIV patients, with a notable post-antifungal effect on fungal proliferation.
Area of Science:
- Mycology
- Antifungal Drug Discovery
- Cellular Biology
Background:
- Cryptococcus species are significant opportunistic fungal pathogens, posing a threat particularly to individuals with compromised immune systems, such as those with HIV/AIDS.
- Miltefosine (MFS), an approved drug, exhibits potential as an alternative antifungal agent for treating cryptococcosis, but its precise mechanism of action against Cryptococcus remains unclear.
Purpose of the Study:
- To elucidate the mechanism of action of miltefosine (MFS) against Cryptococcus neoformans and Cryptococcus gattii.
- To evaluate the efficacy of MFS against both planktonic and biofilm forms of Cryptococcus yeasts.
Main Methods:
- Assessed the inhibitory and fungicidal effects of MFS on planktonic and biofilm cultures of C. neoformans and C. gattii.
- Investigated the post-antifungal effect (PAFE) of MFS on Cryptococcus proliferation.
- Utilized transmission electron microscopy and measured plasma membrane permeability, mitochondrial membrane potential, and reactive oxygen species (ROS) production.
Main Results:
- MFS demonstrated inhibitory and fungicidal activity against planktonic and dispersed biofilm Cryptococcus cells, with reduced sensitivity in sessile biofilm cells.
- A significant post-antifungal effect was observed, delaying proliferation for up to 8.15 hours after short MFS exposure.
- MFS increased plasma membrane permeability (likely via ergosterol interaction), reduced mitochondrial membrane potential, elevated ROS, and induced apoptosis, alongside morphological changes like capsule reduction and cell wall alterations.
Conclusions:
- Miltefosine exhibits fungicidal activity against Cryptococcus by disrupting membrane integrity and inducing apoptosis, suggesting a multi-targeted mechanism.
- The drug's effectiveness against planktonic and dispersed biofilm cells, coupled with its post-antifungal effect, highlights its therapeutic potential for cryptococcosis.
- Further clinical studies are warranted to establish MFS treatment protocols for cryptococcosis.
Related Concept Videos
Apoptosis
Yeast Signaling
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Induced Electric Dipoles
Since the absolute value of potential energy holds no physical meaning, its zero value can be chosen as per...

